僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動物的臨床診斷或治療，非藥用. Ulocuplumab （Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338） is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia （CLL）. Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia （AML）, non-Hodgkin lymphoma （NHL）, and multiple myeloma xenograft models